
Dupixent® demonstrates potential to become first biologic to treat COPD by showing significant reduction in exacerbations in pivotal trial
Dupixent®demonstrates potential to become first biologic to treat COPD by showing significant reduction in exacerbations in pivotal trial The primary and all key secondary endpoints were…